With plates of food in hand and laughter echoing throughout the building, Atlanta University Center students gathered at Morehouse College on Wednesday night for an important community dialogue about ...
For decades scientists have recognized that human immunodeficiency virus (HIV) is a formidable viral pathogen.
A dual-action HIV antibody–drug conjugate forces Env to open, then blocks it, boosting virus neutralization up to tenfold in the lab.
For people living with human immunodeficiency virus (HIV), antiretroviral therapy prevents HIV-infected immune cells from replicating the virus to protect against illness and transmission. Inactive ...
Is there one pill a day to keep me healthy? That's a question that Dr. Chloe Orkin hears a lot from her older HIV patients who take many medications each day to keep the virus under control. "They ...
A new single-pill HIV treatment has proved as effective as regimens of up to 11 tablets a day in suppressing the virus in hard-to-treat patients. It’s “a potential breakthrough for a growing cohort of ...
The giant virus Acanthamoeba polyphaga mimivirus uses a complex of viral proteins to hijack its host’s proteinmaking factories, researchers have found. Credit: Maria Ericsson & Maximilian Fels For ...
The tiny shell protecting the HIV virus resembles a slightly rounded ice cream cone, but there is nothing sweet about it. More than 40 million people worldwide live with AIDS because of this virus, ...
Is a cure for HIV in sight? Since the virus that causes AIDS was identified over 40 years ago, finding a cure has been the holy grail of HIV research and the army of scientists conducting it. I’m ...
Gloved fingers hold a labeled vial of lenacapavir, a clear, yellowish liquid. Lenacapavir (shown) is an antiretroviral medication used to help prevent and treat HIV. Credit: Associated Press While ...
Gilead study finds HIV can evolve to resist lenacapavir, but doing so hampers the virus' replication
Though Gilead Sciences made waves last June with a landmark FDA approval for its twice-yearly HIV preventive Yeztugo (lenacapavir), the first-in-class drug had previously been used as a long-acting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results